Inhibition of mTORC1 by ER stress impairs neonatal β-cell expansion and predisposes to diabetes in the <i>Akita</i> mouse.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30412050.
- Also identified by DOI 10.7554/eLife.38472 and PMC identifier 6294551.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Unresolved ER stress followed by cell death is recognized as the main cause of a multitude of pathologies including neonatal diabetes. A systematic analysis of the mechanisms of β-cell loss and dysfunction in <i>Akita</i> mice, in which a mutation in the proinsulin gene causes a severe form of permanent neonatal diabetes, showed no increase in β-cell apoptosis throughout life. Surprisingly, we found that the main mechanism leading to β-cell dysfunction is marked impairment of β-cell growth during the early postnatal life due to transient inhibition of mTORC1, which governs postnatal β-cell growth and differentiation. Importantly, restoration of mTORC1 activity in neonate β-cells was sufficient to rescue postnatal β-cell growth, and to improve diabetes. We propose a scenario for the development of permanent neonatal diabetes, possibly also common forms of diabetes, where early-life events inducing ER stress affect β-cell mass expansion due to mTOR inhibition.
Medical subject headings
- Diabetes Mellitus
- Endoplasmic Reticulum Stress
- Mechanistic Target of Rapamycin Complex 1
- Proinsulin